(Q52886435)

9 May 2018

title

Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation. (English)

1 reference

9 May 2018

1 reference

4

1 reference

9 May 2018

Claes Göran Tropé

16

object named as

Claes Trope

1 reference

9 May 2018

author name string

Christina Fotopoulou

1

1 reference

9 May 2018

Rongyu Zang

2

1 reference

9 May 2018

Murat Gultekin

3

1 reference

9 May 2018

Ali Ayhan

5

1 reference

9 May 2018

Dongli Liu

6

1 reference

9 May 2018

Rolf Richter

7

1 reference

9 May 2018

Ioana Braicu

8

1 reference

9 May 2018

Sven Mahner

9

1 reference

9 May 2018

Philipp Harter

10

1 reference

9 May 2018

Fabian Trillsch

11

1 reference

9 May 2018

Sanjeev Kumar

12

1 reference

9 May 2018

Michele Peiretti

13

1 reference

9 May 2018

Sean C Dowdy

14

1 reference

9 May 2018

Angelo Maggioni

15

1 reference

9 May 2018

Jalid Sehouli

17

1 reference

9 May 2018

publication date

2 October 2012

1 reference

9 May 2018

Annals of Surgical Oncology

published in

1 reference

9 May 2018

volume

20

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

1348-1354

1 reference

9 May 2018

Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease.

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Surgical standards in the management of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Secondary cytoreductive surgery outcomes of selected patients with paclitaxel/platinum sensitive recurrent epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Tertiary cytoreduction in patients with recurrent ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Best predictors of survival outcome after tertiary cytoreduction in patients with recurrent platinum-sensitive epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2673-Z

10.1245/S10434-012-2673-Z

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

Dimensions Publication ID

1038164487

0 references

1 reference

9 May 2018